Art

J-GLOBAL ID：201502291676214988   Reference number：15A0213415

Post-marketing surveillance of the safety and effectiveness of tacrolimus in 3,267 Japanese patients with rheumatoid arthritis

関節リウマチの日本人患者3267名におけるタクロリムスの安全性と有効性の医薬品市販後調査

Author (6)： TAKEUCHI Tsutomu (Keio Univ. School of Medicine, Tokyo, JPN) ,  KAWAI Shinichi (Toho Univ. School of Medicine, Tokyo, JPN) ,  YAMAMOTO Kazuhiko (Univ. Tokyo Graduate School of Medicine, Tokyo, JPN) ,  HARIGAI Masayoshi (Tokyo Medical and Dental Univ., Tokyo, JPN) ,  ISHIDA Kota (Astellas Pharma Inc, Tokyo, JPN) ,  MIYASAKA Nobuyuki (Tokyo Medical and Dental Univ., Tokyo, JPN)
Material： Modern Rheumatology  (Mod Rheumatol)
Volume： 24  Issue： 1  Page： 8-16  Publication year： 2014 
JST Material Number： L5142A  ISSN： 1439-7595  Document type： Article
Article type： 原著論文  Country of issue： United Kingdom (GBR)  Language： ENGLISH (EN)

Thesaurus term： human ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=15A0213415&from=J-GLOBAL&jstjournalNo=L5142A") }}

JST classification (2)： Clinical application of immunotherapeutic agents and blood preparations  (GW22020O) ,  Drug therapy(=pharmacotherapy)for musculoskeletal diseases  (GG05020D)

Substance index (2)： Tacrolimus ,  Methotrexate

Reference (39)：

• Breedveld FC, Dayer JM. Leflunomide: mode of action in the treatment of rheumatoid arthritis. Ann Rheum Dis. 2000;59: 841-9.
• Weyand CM. New insights into the pathogenesis of rheumatoid arthritis. Rheumatology. 2000;39(Suppl 1):3-8.
• Arend WP, Dayer JM. Inhibition of the production and effects of interleukin-1 and tumor necrosis factor alpha in rheumatoid arthritis. Arthritis Rheum. 1995;38:151-60.
• Kino T, Hatanaka H, Miyata S, Inamura N, Nishiyama M, Yajima T, et al. FK-506, a novel immunosuppressant isolated from a Streptomyces. II. Immunosuppressive effect of FK-506 in vitro. J Antibiot (Tokyo). 1987;40:1256-65.
• Sakuma S, Kato Y, Nishigaki F, Sasakawa T, Magari K, Miyata S, et al. FK506 potently inhibits T cell activation induced TNF-a and IL-1b production in vitro by human peripheral blood mononuclear cells. Br J Pharmacol. 2000;130:1655-63.

Terms in the title (6)： 関節リウマチ ,  日本人 ,  患者 ,  タクロリムス ,  安全性 ,  医薬品市販後調査